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Themammalian genome has evolved to encode a battery of mechanisms, to mitigate a pro-
gression in the life cycle of an invasive viral pathogen. Although apparently disadvantaged by
their dependence on the host biosynthetic processes, an immensely faster rate of evolution
provides viruses with an edge in this conﬂict. In this review, I have discussed the potential
anti-virus activity of inositol-requiring enzyme 1 (IRE1), a well characterized effector of the
cellular homeostatic response to an overloading of the endoplasmic reticulum (ER) protein-
folding capacity. IRE1, an ER-membrane-resident ribonuclease (RNase), upon activation
catalyses regulated cleavage of select protein-coding and non-coding host RNAs, using an
RNase domain which is homologous to that of the known anti-viral effector RNaseL. The
latter operates as part of the Oligoadenylate synthetase OAS/RNaseL system of anti-viral
defense mechanism. Protein-coding RNA substrates are differentially treated by the IRE1
RNase to either augment, through cytoplasmic splicing of an intron in the Xbp1 transcript,
or suppress gene expression. This referred suppression of gene expression is mediated
through degradative cleavage of a select cohort of cellular RNA transcripts, initiating the
regulated IRE1-dependent decay (RIDD) pathway. The review ﬁrst discusses the anti-viral
mechanism of the OAS/RNaseL system and evasion tactics employed by different viruses.
This is followed by a review of the RIDD pathway and its potential effect on the stability
of viral RNAs. I conclude with a comparison of the enzymatic activity of the two RNases
followed by deliberations on the physiological consequences of their activation.
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INTRODUCTION
Establishment of infection by a virus, even in permissive host
cells, is beset with a plethora of challenges from innate-antiviral
and cell-death pathways. Therefore, the host response to a virus
infection might prove to be inhibitory for the viral life cycle in
a direct or an indirect manner. The direct mechanism involves
expression of multiple anti-viral genes that have evolved to recog-
nize, react, and thereby rid the infected host of the viral nucleic
acid (Zhou et al., 1997; Thompson et al., 2011). On the other hand
the pathways, e.g., those that culminate in initiating an apop-
totic death for the host cell, indirectly serve to limit the spread
of virus (Roulston et al., 1999). A major difference between these
twomechanisms is that while the former response is transmissible
to neighboring uninfected cells through interferon (IFN) signal-
ing, the latter is observed mostly in cis. Recent reports, however,
have demonstrated transmission of an apoptotic signal between
cells that are in contact through gap junctions, although such a
signaling from an virus infected host cell to an uninfected one is
not known yet (Cusato et al., 2003; Udawatte and Ripps, 2005;
Kameritsch et al., 2013). Successful viral pathogens, through a
process of active selection, have evolved to replicate and simul-
taneously evade or block either of these host responses. The viral
nucleic acids which could be the genome (positive-sense single-
stranded RNA virus) or RNA derived from transcription of the
genome [negative-stranded single-sense RNA or double-stranded
RNA (dsRNA) or DNA virus], offer critical targets for both detec-
tion and eradication. The viral nucleic acid targeting armaments
in the host arsenal include those that recognize the associated
molecular patterns like toll-like receptors (TLRs), DDX58 (or
RIG-1), IFIH1 (or MDA5), IFIT proteins [IFN-stimulated genes
(ISG)56 and ISF54], etc. (Aoshi et al., 2011; Bowzard et al., 2011;
Jensen and Thomsen, 2012). This is followed by IFN signaling
and expression or activation of factors that target the inducer for
degradation or modiﬁcation like OAS/ribonuclease L (RNaseL)
system, APOBEC3, MCPIP1, the ZC3HAV1/exosome system and
RNAi pathways (Gao et al., 2002; Sheehy et al., 2002; Guo et al.,
2007; Dafﬁs et al., 2010; Sidahmed and Wilkie, 2010; Schmidt
et al., 2012; Cho et al., 2013a; Lin et al., 2013). In this review we
focus on two proteins containing homologous RNase domains,
RNaseL with a known direct antiviral function and Inositol-
requiring enzyme 1 (IRE1 or ERN1) which has an RNaseL-like
RNase domain with a known role in homeostatic response to
unfolded proteins in the endoplasmic reticulum (ER) and a
potential to function as an antiviral (Figure 1; Tirasophon et al.,
2000).
DEGRADATION OF VIRAL RNA BY RNaseL AND VIRAL
EVASION
In mammalian cells the tell-tale signs of RNA virus infection,
like the presence of cytosolic RNA having 5′-ppp or extensive
(>30 bp) dsRNA segments are detected by dedicated pathogen
associated molecular pattern receptors (PAMPs) or pattern recog-
nition receptors (PRRs) in the host cell, like RIG-1, MDA5, and
the IFIT family of proteins (Aoshi et al., 2011; Bowzard et al., 2011;
Vabret and Blander, 2013). The transduction of a signal of this
recognition results in the expression of IFN genes the products
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FIGURE 1 | Schematic representation of the ribonuclease activity of
IRE1 and RNaseL showing cross-talk between the paths catalysed by
the enzymes. The ﬁgure shows activation of RNase activity following
dimerization triggered by either accumulation of unfolded proteins in the
ER-lumen or synthesis of 2–5A by the enzyme OAS, respectively, for IRE1
and RNaseL. The cleavage of Xbp1u by IRE1 releases an intron thus
generating Xbp1s. The IRE1 targets in RIDD pathway or all RNaseL
substrates are shown to undergo degradative cleavage. The cleavage
products generated through degradation of the respective substrate is
shown to potentially interact with RIG-I thereby leading to Interferon
secretion and trans-activation of Oas genes through Interferon signaling.
Abbreviations: RIG-I = retinoic acid inducible gene-I, Ifnb = interferon beta
gene loci, IFN = interferons, ISG = interferon-sensitive genes,
2–5A = 2′–5′ oligoadenylates.
of which upon secretion outside the cell bind to cognate recep-
tors, initiating further downstream signaling (Figure 1; Randall
and Goodbourn, 2008). The genes that are regulated as a result
of IFN signaling are termed as IFN-stimulated or IFN-regulated
genes (ISGs or IRGs; Sen and Sarkar, 2007; Schoggins and Rice,
2011). Oligoadenylate synthetase or OAS genes are canonical
ISGs that convert ATP into 2′–5′ linked oligoadenylates (2–5A)
by an unique enzymatic mechanism (Figure 1; Hartmann et al.,
2003). Further, they are RNA-binding proteins that function like
PRRs, in a way that the 2–5A synthesizing activity needs to be
induced through an interaction with dsRNA (Minks et al., 1979;
Hartmann et al., 2003). In a host cell infected by an RNA virus,
such dsRNA is present in the form of replication-intermediates
(RI), which are synthesized by the virus-encoded RNA-dependent
RNA polymerases (RdRp) and subsequently used by the same
enzyme to synthesize more genomic RNA, through asymmetric
transcription (Weber et al., 2006). However, the replications com-
plexes (RCs) harboring these RI molecules are found secluded
inside host-membrane derived vesicles, at least in positive-strand
RNA viruses, a group which contains many human pathogens
(Uchil and Satchidanandam, 2003; Denison, 2008). Reports from
different groups suggest OAS proteins to be distributed both in
the cytoplasm as well as in membrane-associated fractions, per-
haps indicating an evolution of the host anti-viral methodologies
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towards detection of the membrane-associated viral dsRNAs
(Marie et al., 1990; Lin et al., 2009). DNA viruses on the other
hand, produce dsRNA by annealing of RNA derived from tran-
scription of both strands in the same viral genomic loci, which
are probably detected by the cytoplasmic pool of OAS proteins
(Jacobs and Langland, 1996; Weber et al., 2006). Post-activation
the OAS enzymes synthesize 2–5A molecules in a non-processive
reaction producing oligomers which, although potentially rang-
ing in size from dimeric to multimeric, are functionally active
only in a trimeric or tetrameric form (Dong et al., 1994; Sarkar
et al., 1999; Silverman, 2007). These small ligands, which bear
phosphate groups (1–3) at the 5′ end and hydroxyl groups at
the 2′ and 3′ positions, serve as co-factor which can specif-
ically interact with and thereby allosterically activate, existing
RNaseL molecules (Knight et al., 1980; Zhou et al., 1997, 2005;
Sarkar et al., 1999). As part of a physiological control system these
2–5A oligomers are quite unstable in that they are highly sus-
ceptible to degradation by cellular 5′-phosphatases and PDE12
(2′-phosphodiesterase; Silverman et al., 1981; Johnston andHearl,
1987; Kubota et al., 2004; Schmidt et al., 2012). Viral strategies to
evade or overcome this host defense mechanism ranges from pre-
venting IFN signaling which would hinder the induction of OAS
expression or thwarting activation of expressed OAS proteins by
either shielding the viral dsRNA from interacting with it or mod-
ulating the host pathway to synthesize inactive 2–5A derivatives
(Cayley et al., 1984; Hersh et al., 1984; Rice et al., 1985; Maitra
et al., 1994; Beattie et al., 1995; Rivas et al., 1998; Child et al.,
2004; Min and Krug, 2006; Sanchez and Mohr, 2007; Sorgeloos
et al., 2013). Shielding of viral RNA from interacting with OAS
is possible through enclosure of dsRNA replication intermediates
in membrane enclosed compartments as observed in many ﬂa-
viviruses (Ahlquist, 2006; Miller and Krijnse-Locker, 2008; Miorin
et al., 2013).
RNaseL is a 741 amino acid protein containing three predom-
inantly structured region, an N-terminal ankyrin repeat domain
(ARD), a middle catalytically inactive pseudo-kinase (PK) and
a C-terminal RNase domain (Figure 2A; Hassel et al., 1993;
Zhou et al., 1993). The activity of the RNase domain is neg-
atively regulated by the ARD, which is relieved upon binding
of 2–5A molecules to ankyrin repeats 2 and 4 followed by a
conformational alteration (Figure 1; Hassel et al., 1993; Tanaka
et al., 2004; Nakanishi et al., 2005). In support of this contention,
deletion of the ARD has been demonstrated to produce consti-
tutively active RNaseL, although with dramatically lower RNase
activity (Dong and Silverman, 1997). However, recent reports
suggest that while 2–5A links the ankyrin repeats from adja-
cent molecules leading to formation of dimer and higher order
structures, at sufﬁciently high in vitro concentrations, RNaseL
could oligomerize even in the absence of 2–5A (Han et al.,
2012). Nonetheless, in vivo the RNaseL nuclease activity still
seems to be under the sole regulation of 2–5A (Al-Saif and
Khabar, 2012). In order to exploit this dependence, multiple
viruses like mouse hepatitis virus (MHV) and rotavirus group
A (RVA) have evolved to encode phosphodiesterases capable of
hydrolysing the 2′–5′ linkages in 2–5A and thereby attenuate the
RNaseL cleavage activity (Zhao et al., 2012; Zhang et al., 2013). In
addition to 5′-phosphatases and 2′-phosphodiesterases to reduce
FIGURE 2 | Schematic representation of distinct protein domains in
human RNaseL and IRE1. (A)The domains homologous between RNaseL
and IRE1 are shaded identically. The domain name abbreviations denote the
following: ARD = ankyrin repeat domain; LD = luminal domain; PK =
protein kinase domain; KEN = kinase extension nuclease domain. The
amino acid positions bordering each domain are numbered. The schematic
drawings are not according to scale. (B) ClustalW alignment of primary
sequence from a segment of the PK domain indicating amino acid residues
which are important for interacting with nucleotide cofactors. The
conserved lysine residues, critical for this interaction (K599 for IRE1 and
K392 in RNaseL) are underlined. (C) Alignment of the KEN domains in
RNaseL and IRE1. The amino acids highlighted and numbered in IRE1 are
critical for the IRE1 RNase activity (Tirasophon et al., 2000).
the endogenous 2–5A levels, mammalian genomes encode post-
transcriptional and post-translation inhibitors of RNaseL activity
in the form of microRNA-29 and the protein ABCE1 (RNaseL
inhibitor or RLI), respectively (Bisbal et al., 1995; Lee et al., 2013).
Direct inhibition of RNaseL function is also observed upon infec-
tion by Picornaviruses through, either inducing the expression of
ABCE1 or exercising a unique inhibitory property of a segment of
the viral RNA (Martinand et al., 1998, 1999; Townsend et al., 2008;
Sorgeloos et al., 2013).
Once activated by 2–5A, RNaseL can degrade single-stranded
RNA irrespective of its origin (virus or host) although there seems
to exist a bias towards cleavage of viral RNA (Wreschner et al.,
1981a; Silverman et al., 1983; Li et al., 1998). RNA sequences
that are predominantly cleaved by RNaseL are U-rich with the
cleavage points being typically at the 3′ end of UA or UG or
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UU di-nucleotides, leaving a 5′-OH and a 3′-monophosphate in
the cleavage product (Floyd-Smith et al., 1981; Wreschner et al.,
1981b). A recent report shows a more general consensus of 5′-
UNN-3′ with the cleavage point between the second and the
third nucleotide (Han et al., 2014). Cellular targets of RNaseL
include both ribosomal RNA (rRNA) and mRNAs, the latter
predominantly representing genes involved in protein biosyn-
thesis (Wreschner et al., 1981a; Al-Ahmadi et al., 2009; Andersen
et al., 2009). Additionally, RNaseL activity can also degrade spe-
ciﬁc ISG mRNA transcripts and thereby attenuate the effect of
IFN signaling (Li et al., 2000). Probably an evolution towards
insulating gene expression from RNaseL activity is observed in
the coding region of mammalian genes where the UU/UA din-
ucleotide frequency is rarer (Bisbal et al., 2000; Khabar et al.,
2003; Al-Saif and Khabar, 2012). Perhaps not surprisingly, with
a much faster rate of evolution, similar observations have been
made with respect to evasion of RNaseL mediated degradation
by viral RNAs too (Han and Barton, 2002; Washenberger et al.,
2007). Moreover, nucleoside modiﬁcations in host mRNAs, rarely
observed in viral RNAs, have also been shown to confer pro-
tection from RNaseL (Anderson et al., 2011). In addition to
directly targeting viral RNA, the reduction in functional ribo-
somes and ribosomal proteinmRNA affects viral protein synthesis
and replication in an indirect manner. Probably, as a reﬂection
of these effects on cellular RNAs, RNaseL is implicated as one
of the factors determining the anti-proliferative effect of IFN
activity (Hassel et al., 1993). The anti-viral activity of RNaseL
extends beyond direct cleavage of viral RNA, through stimu-
lation of RIG-I by the cleavage product (Malathi et al., 2005,
2007, 2010). A global effect of RNaseL is observed in the form
of autophagy induced through c-jun N-terminal kinase (JNK)
signaling and apoptosis, probably as a consequence of rRNA
cleavage (Li et al., 2004; Chakrabarti et al., 2012; Siddiqui and
Malathi, 2012). RNaseL has also been demonstrated to play a
role in apoptotic cell death initiated by pharmacological agents
extending the physiological role of this pathway beyond the
boundary of being only an anti-viral mechanism (Castelli et al.,
1997, 1998).
IRE1 AND THE RIDD PATHWAY
The ER serves as a conduit for maturation of cellular proteins
which are either secreted or destined to be associated with a
membrane for its function. An exclusive microenvironment (high
Calcium ion and unique ratio of reduced to oxidized glutathione)
along with a battery of ER-lumen resident enzymes (foldases,
chaperones, and lectins) catalyse/mediate the necessary folding,
disulﬁde-bond formation, and glycosylation reactions (Schroder
and Kaufman, 2005). A perturbation of the folding capacity, due
to either physiological disturbances or virus infection, can lead
to an accumulation of unfolded proteins in the ER lumen, which
signals an unfolded protein response (UPR). UPR encompasses a
networked transcriptional and translational gene-expression pro-
gram, initiated by three ER-membrane resident sensors namely
IRE1 or ERN1, PKR-like ER Kinase (PERK or EIF2AK3) and
activating transcription factor 6 (ATF6; Hetz, 2012). IRE1 is a
type I single-pass trans-membrane protein in which, similar to
what is observed with RNaseL, the N-terminal resident in the
ER lumen serves as sensor and the cytosolic C-terminal as the
effector (Figure 1; Chen and Brandizzi, 2013). The IRE1 coding
gene is present in genomes ranging from yeast to mammals and
in the latter is ubiquitously expressed in all tissues (Tirasophon
et al., 1998). Signal transduction by stimulated IRE1 initiates
multiple gene regulatory pathways with either pro-survival or
pro-apoptotic consequences (Kaufman, 1999). During homeosta-
sis or unstressed conditions the sensor molecules are monomeric,
a state maintained co-operatively by the “ absence” of unfolded
proteins and the “presence” of HSPA5 (GRP78 or Bip, an ER-
resident chaperone) molecules bound to a membrane-proximal
disordered segment of the protein in the ER-lumen-resident N-
terminus (Credle et al., 2005). Accumulated unfolded proteins
in the lumen triggers coupling of this domain from adjacent
sensor molecules through a combination of (a) titration of the
bound HSPA5 chaperone molecules and (b) direct tethering by
malfolded protein molecules (Shamu and Walter, 1996; Credle
et al., 2005; Aragon et al., 2009; Korennykh et al., 2009). Abut-
ting of the luminal domains juxtapose the cytosolic C-terminal
segments, leading to an aggregation of the IRE1 molecules into
distinct ER-membrane foci (Kimata et al., 2007; Li et al., 2010).
The C-terminal segment has a serine/threonine kinase domain
and a RNase domain homologous to that of RNaseL (Figure 1;
Tirasophon et al., 1998, 2000). A trans-autophosphorylation by
the kinase domain allosterically activates the RNase domain (Tira-
sophon et al., 2000; Lee et al., 2008; Korennykh et al., 2009). In
fact, exogenous over-expression of IRE1 in mammalian cells lead
to activation suggesting that, under homeostatic conditions, the
non-juxtaposition of cytosolic domains maintains an inactive
IRE1 (Tirasophon et al., 1998). Once activated, IRE1 performs
cleavage of a variety of RNA substrates mediated by its RNase
domain, in addition to phosphorylating and thereby activating
JNK (Cox and Walter, 1996; Urano et al., 2000). Depending on
the RNA substrate, the cleavage catalyzed by IRE1 RNase pro-
duces differential consequence. Although scission of the Xbp1
mRNA transcript at two internal positions is followed by splic-
ing of the internal segment through ligation of the terminal
cleavage products, that in all other known IRE1 target RNA is
followed by degradation (Figure 1; Sidrauski and Walter, 1997;
Calfon et al., 2002). The latter mode of negative regulation of
gene expression is termed as the regulated IRE1-dependent decay
(RIDD) pathway (Hollien and Weissman, 2006; Oikawa et al.,
2007; Iqbal et al., 2008; Lipson et al., 2008). Gene transcripts
regulated by RIDD pathway includes that from IRE1 (i.e., self-
transcripts), probably in a negative feedback loop mechanism
(Tirasophon et al., 2000). In addition to protein coding RNA,
RIDD pathway down-regulates the level of a host of microRNA
precursors (pre-miRNAs) and can potentially cleave in the anti-
codon loop of tRNAPhe (Korennykh et al., 2011; Upton et al.,
2012).
The IRE1 RNase domain cleaves the Xbp1u (u for unspliced)
mRNA transcript at two precise internal positions within the open
reading frame (ORF) generating three segments, the terminal two
of which are ligated by a tRNA ligase in yeast and by an unknown
ligase in mammalian cells, to produce the Xbp1s (s for spliced)
mRNA transcript (Figure 1; Yoshida et al., 2001). The Xbp1s thus
generated has a longer ORF, which is created by a frame-shift
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in the coding sequence downstream of the splice site (Cox and
Walter, 1996; Calfon et al., 2002). A similar dual endonucleolytic
cleavage is also observed to initiate the XRN1 and Ski2-3-8 depen-
dent degradation of transcripts in the RIDD degradation pathway
(Hollien and Weissman, 2006). The RIDD target transcript genes
are predominantly those that encode membrane-associated or
secretory proteins and which are not necessary for ER protein-
folding reactions (Hollien and Weissman, 2006). The cleavage of
Xbp1 and the RIDD-target transcripts constitute homeostatic or
pro-survival response by IRE1 since XBP1S trans-activates genes
encoding multiple chaperones (to fold unfolded proteins) and the
ERAD pathway genes (to degrade terminally misfolded proteins)
whereas RIDD reduces ﬂux of polypeptides entering the ER lumen
(Lee et al., 2003; Hollien and Weissman, 2006). On the other
hand, cleavage of pre-miRNA transcripts which are processed
in the cell to generate CASPASE-2 mRNA (Casp2) controlling
miRNAs, constitutes the pro-apoptotic function of IRE1 (Upton
et al., 2012). Another pro-apoptotic signal from IRE1 emanates
from signaling through phosphorylation of JNK1 (Urano et al.,
2000). Although in the initial phase RIDD activity does not cleave
mRNAs encoding essential ER proteins, at later stages of chronic
UPR such transcripts are rendered susceptible to degradation pro-
moting apoptosis induction (Han et al., 2009; Bhattacharyya et al.,
2014).
Infection of mammalian cells by a multitude of viruses induce
anUPRwhich is sometimes characterizedby suppressionof signal-
ing by one ormore of the three sensor(s; Su et al., 2002; Tardif et al.,
2002; He, 2006; Yu et al., 2006, 2013; Medigeshi et al., 2007; Zhang
et al., 2010;Merquiol et al., 2011). Among these at least two viruses
from diverse families, HCMV (a DNA virus) and hepatitis C virus
(a hepacivirus), interfere with IRE1 signaling by different mecha-
nism (Tardif et al., 2004; Stahl et al., 2013). An observed inhibition
of any cellular function by a virus infection could suggest a poten-
tial anti-virus function for it, which the virus has evolved to evade
through blocking some critical step(s). In both the cases men-
tioned above, stability of the viral proteins seems to be affected by
ERAD-mediated degradation, although other potential anti-viral
effect of IRE1 activation are not clear yet (Isler et al., 2005; Saeed
et al., 2011). Interestingly, host mRNA fragments produced fol-
lowing IRE1 activation during bacterial infection, has been shown
to activate RIG-I signaling (Figure 1; Cho et al., 2013b). Theo-
retically, other functions of IRE1 can also have anti-viral effect
necessitating its inhibition for uninhibited viral replication. It is,
however, still not clear whether IRE1 is able to cleave any viral
RNA (or mRNA) in a manner similar to that of other RIDD tar-
gets (Figure 1). The possibilities of such a direct anti-viral function
are encouraged by the fact that all these viruses encode at least one
protein which, as part of its maturation process, requires glyco-
sylation and disulﬁde-bond formation. Such a necessity would
entail translation of the mRNA encoding such a protein, which in
case of positive-sense single-stranded RNA viruses would mean
the genome, in association with the ER-membrane (Figure 1;
Lerner et al., 2003). Additionally for many RNA viruses, repli-
cation complexes are housed in ER-derived vesicular structures
(Denison, 2008; den Boon et al., 2010). Considering the proximity
of IRE1 and these virus-derived RNAs it is tempting to specu-
late that probably at some point of time in the viral life cycle one
or more virus-associated RNA would be susceptible to cleavage
by IRE1. However, studies with at least two viruses have shown
that instead of increasing viral titre, inhibiting the RNase activ-
ity of activated IRE1 has an opposite effect (Hassan et al., 2012;
Bhattacharyya et al., 2014). This implies potential beneﬁts of IRE1
activation through one or more of the following, (a) expression of
chaperones or other pro-viral molecules downstream of XBP1S-
upregulation or JNK-activation, (b) cleavage of potential anti-viral
gene mRNA transcripts by RIDD activity. However, the mode of
protection for the viral RNA fromRIDD activity is still not clear. It
is possible that the viral proteins create a subdomain within the ER
membrane, which through some mechanism excludes IRE1 from
diffusing near the genomic RNA, thereby protecting the repli-
cation complexes (Denison, 2008). It is therefore probably not
surprising that single-stranded plus-sense RNA viruses encode a
polyprotein, which produces replication complexes in cis, pro-
moting formation of such subdomains (Egger et al., 2000). The
fact that IRE1 forms bulky oligomers of higher order probably
aggravates such an exclusion of the activated sensor molecules
from vicinity of the viral replication complexes. The UPR signal-
ing eventually attenuate during chronic ER-stress and since that
is what a virus-induced UPR mimics, probably the viral RNA
needs protection only during the initial phase of UPR activation
(Lin et al., 2007). Since the choice of RIDD target seems to be
grossly driven towards mRNAs that encode ER-transitory but are
not ER-essential proteins, it is also possible that one or more viral
protein have evolved to mimic a host protein the transcript of
which is RIDD-resistant (Hollien and Weissman, 2006). Most of
the RIDD target mRNA are observed to be ER-membrane asso-
ciated, the proximity to IRE1 facilitating association and cleavage
(Figure 1; Hollien andWeissman, 2006). Although ER-association
for an mRNA is possible without the mediation of ribosomes,
Gaddam and co-workers reported that continued association with
polysomes for a membrane-bound mRNA can confer protection
from IRE1 cleavage (Cui et al., 2012; Gaddam et al., 2013). This
would suggest important implications for the observed refractory
nature of Japanese encephalitis virus (JEV) and inﬂuenza virus
RNA to RIDD cleavage (Hassan et al., 2012; Bhattacharyya et al.,
2014). In contrast to Inﬂuenza virus, ﬂaviviruses (which include
JEV) do not suppress host protein synthesis implying the absence
of a global inhibition on translation as would be expected during
UPR (Clyde et al., 2006; Edgil et al., 2006). Therefore, a continued
translation of viral RNA in spite of UPR activation can in principle
confer protection from the pattern of RNA cleavage observed in
the RIDD pathway.
COMPARISON OF IRE1 AND RNaseL
IRE1 and RNaseL, in addition to biochemical similarities in pro-
tein kinase domain and structural similarities in their RNase
domain, share the functional consequences of their activation
in initiating cellular apoptosis through JNK signaling (Table 1
and Figure 2; Liu and Lin, 2005; Dhanasekaran and Reddy,
2008). Though initial discoveries were made in the context of
homeostatic and anti-viral role for the former and latter, differ-
ences between the pathways are narrowed by further advances
in research. In the same vein, while inhibition of IRE1 signal-
ing in virus infected cells indicates a potential anti-viral role,
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Table 1 | A comparison of the structural and biochemical properties of RNaseL and IRE1, showing similarities and differences.
Similarities
RNaseL IRE1
Inactive state Monomeric
Active state Oligomeric
Factor driving oligomerization Catenation of by 2–5A bound to
ankyrin repeats of multiple
monomers
Titration of HSPA5 bound to luminal domain and catenation of
the same from multiple monomers by unfolded proteins
Activation upon exogenous overexpression Yes (demonstrated in vitro for RNaseL)
Position of ligand–receptor and RNase domain N- and C-terminal, respectively
Ribonuclease domain KEN or kinase-extension homology domain
Role of PK domain in activating RNase Nucleotide binding, even in absence of hydrolysis, to conserved residue in protein-kinase like domain
is necessary for RNase activity (Tirasophon et al., 1998; Dong and Silverman, 1999; Papa et al., 2003;
Lin et al., 2007)
Nature of RNase substrates Both 28S rRNA and mRNAs IRE1β can cleave both 28S rRNA and mRNA while IRE1α
substrates include only mRNAs (Iwawaki et al., 2001)
Dissimilarities
Autophosphorylation No Yes
Cleavage substrates Beside 28S rRNA, predominantly
cleaves mRNAs encoding ribosomal
proteins (Andersen et al., 2009)
Xbp1u and other mRNAs in addition to microRNA precursors
which are targeted as part of the RIDD pathway
Selection of cleavage site Cleaved between 2nd and 3rd
nucleotide positions of UN/N sites
(Han et al., 2014)
RNA sequence with the consensus of 5′-CUGCAG-3′ in
association with a stem-loop (SL) structure essential for
recognition of Xbp1u and other mRNAs (Oikawa et al., 2010)
association of RNaseL mutations with generation of prostate can-
cer extends the ambit of inﬂuence of this anti-viral effector to
more non-infectious physiological disorders (Silverman, 2003).
Biochemically, the similarity in their RNase domains does not
extend to the choice of either substrates or cleavage point, which
are downstream of UU or UA in RNaseL and downstream of
G (predominantly) for IRE1 (Figure 2C; Yoshida et al., 2001;
Hollien and Weissman, 2006; Upton et al., 2012). Further, while
RNaseL cleaves pre-dominantly in single-stranded region, IRE1
seems to cleave equally well in single- and double-stranded region
(Upton et al., 2012). However, a recent report suggested a con-
sensus cleavage site with the sequence UN/N, in RNaseL targets
and in those mRNAs that are cleaved by IRE1 as part of the RIDD
pathway (Han et al., 2014). Access to potential cleavage substrate
for RNaseL is conjectured to be facilitated through its associa-
tion with polyribosomes, while no such association is known for
IRE1 (Salehzada et al., 1991). Possibilities exist that IRE1 would
have preferential distribution in the rough ER which, upon activa-
tion, would give it ready access to mRNAs for initiating the RIDD
pathway.
In the context of a virus infection, the pathway leading from
both these proteins have the potential to lead to cell death.
Notwithstanding the fact that this might be an efﬁcient way of
virus clearance, it also portends pathological outcomes for the
infected organism. Future research would probably lead to design
of drugs targeting these proteins based on the structural homology
of their effector domains, regulating the pathological denoue-
ment of their activation without compromising their anti-viral
or potential anti-viral functions.
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